Funding

Tavo Biotherapeutics

United States · Biotech · Healthtech

Develops novel therapeutics for glaucoma and retinal diseases

Visit tavobio.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$17MPolaris Partners — Role not disclosedPureos Bioventures — Role not disclosedTau Capital — Role not disclosed

Investors

Polaris PartnersSeries APureos BioventuresSeries ATau CapitalSeries A

Coverage

Jun 2, 2026Tavo Biotherapeutics · Series A

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcestavobio.com ↗